Leading change in bladder cancer
Making an impact beyond healthcare
Photocure’s corporate social responsibility (CSR)
At Photocure, we take matters related to our CSR seriously. We know the impact of our actions can be felt far beyond the solutions we produce and the patients whose lives we touch. It reaches out to working conditions throughout the supply chain and environmental and social responsibilities too. Our approach to CSR is to make it part of our company’s fabric. In every area we make an impact, we aim to make a positive difference.
"Being part of the solution rather than the problem, is anchored in our DNA"
Dan Schneider, President and CEO of Photocure
Our Ethical Principles
Everyone at Photocure is committed to act in an ethical and compliant manner. It is what we expect of each employee – in every country and in every function. We also expect high ethical standards of everyone who acts on our behalf, and we encourage our business partners to implement ethics standards compatible with our own.
Sustainability
Photocure is proud to be a signatory of the United Nations Global Compact (UNGC); the world’s largest corporate sustainability initiative. Being a signatory means we are part of a global movement, striving to become a sustainable and responsible company. As a signatory we must adhere to the ten principles of the UNGC within human rights, labour, environment, and anti-corruption.
Our strong commitment to conduct our business in a lawful and ethical manner includes engaging with suppliers and partners who are also committed to this cause and share our principles. Our suppliers and partners are viewed as an extension of Photocure, and therefore should adhere to guidelines for ethical business practices. We work closely with our suppliers to ensure goods and services that are produced are provided in compliance with environmental, social, and ethical standards set out in the Suppliers and Partner Code of Conduct.
Human Rights and Transparency Act
Photocure ASA ("Photocure") is covered by the Norwegian Transparency Act and is obliged to publish an annual due diligence statement regarding our investigations whether there are any actual or potential adverse impacts on human rights or decent working conditions in our own operations, our supply chain and other business relationships.
For questions regarding the statement or Photocure's due diligence work according to the Human Rights and Transparency Act, please contact: compliance@photocure.com.
Transparency
Interaction with healthcare professionals
Photocure interacts with healthcare organizations (HCO) and healthcare professionals (HCP) every day. Both the medical community and the pharmaceutical industry have a common interest in developing new and better products and to ensure that the existing ones are used in a way that benefits patients. We believe that a close collaboration between scientists, physicians and the industry is crucial in securing the development and effective use of new drugs and technologies to improve patient care. We also truly believe that the interaction between healthcare personnel or organizations and the industry should be open and transparent in order to succeed in achieving the best healthcare for every patient. We adhere to industry ethical codes in all our activities across all markets.
A transparent disclosure regarding payments and transfers of value between the medical community and the pharmaceutical industry is important to keep a trustworthy and healthy relationship with patients, HCPs, government officials and the public and it strengthens our commitment to high ethical business standards.
Please use the links below to download our disclosure reports (Europe):
The company discloses board and governance guidelines annually in the annual report and on this website (Corporate Governance Policy and Annual Review). For more information about Corporate Governance, Audit Committee and ESG Board Advisor, please see the Photocure corporate governance policy in the 2023 annual report.
Nomination Committee
Photocure has a Nomination Committee making recommendations to the general meeting regarding election of shareholder-elected members of the Board of Directors, remuneration to the members of the Board of Directors, election of members to the Nomination Committee and remuneration to the members of the Nomination Committee.
The nomination committee shall consist of two or three members who shall be shareholders or shareholder representatives. The members shall be elected by the general meeting for a term of one year. The nomination committee shall give its recommendation to the general meeting on election of and compensation to members of the board of directors and members of the nomination committee. The proposals shall be justified. Shareholders are encouraged to submit proposals to the nomination committee for candidates for election to the board of directors. Such proposals must be in writing and justified and be submitted minimum 2 months before the general meeting if they are to be considered by the nomination committee.
The nomination committee currently consists of the following three members: Robert Blatt (chairperson), Hans Peter Bøhn and Lars Viksmoen. The current members have been elected by the general meeting with a term until the Company’s ordinary general meeting in 2024. All members are independent of the board of directors and senior management.
Contact the Nomination Committee Chairperson: nomination@photocure.com